Could when you eat help the brain in Huntington’s disease? A small pilot study suggests it might — people with early Huntington’s who limited their eating to a daily window showed improvements in several disease markers. But the researchers are the first to say the result is a hint, not proof.

The disease

Huntington’s disease is a devastating inherited neurodegenerative disorder caused by a single faulty gene that produces a toxic form of the huntingtin protein. That protein accumulates and progressively kills brain cells, causing movement problems, cognitive decline and psychiatric symptoms. There is no cure, and treatments mainly manage symptoms — so any hint of a way to slow the underlying process draws interest.

What the study did

Researchers at Oregon Health & Science University ran a 12-week pilot in 20 participants with early-stage Huntington’s, who limited food intake to a 6–8 hour daily window (a form of time-restricted eating). The findings were published in Nature Metabolism.

What improved

The team reported movement in the right direction on three measures. On a composite disease-severity scale (the cUHDRS), participants improved by about 0.5 points — notable because this score typically declines by roughly a point per year. A blood marker of nerve damage, neurofilament light, dropped 13% (it usually rises as the disease progresses). And the participants’ cells showed improved mitochondrial (energy) function.

The proposed mechanism

Why might skipping late-night snacks help brain cells? The leading idea is hormesis: “fasting acts as a mild stressor that prompts cells to become more efficient,” explained researcher Russell Wells — potentially boosting cellular cleanup processes (like autophagy, which helps clear toxic proteins) and making brain cells more resilient. In Huntington’s, where a toxic protein accumulates, better cellular housekeeping is a biologically sensible target.

The serious caveats

This is where restraint is essential. The study had no control group, so there’s no way to know how these participants would have fared without the intervention — improvements could reflect placebo effects, extra attention, or measurement variability. The sample was tiny (20 people), and the researchers explicitly state the findings “should not be considered proof” of benefit. Larger randomized controlled trials are needed, which the team is pursuing.

Why it matters

Even as a preliminary signal, the study is valuable: it’s a low-cost, low-risk lifestyle approach worth testing rigorously in a disease with few options, and it fits a broader scientific theme that metabolic health and brain health are linked. But people with Huntington’s should not change their diet based on this alone — nutrition is delicate in neurodegenerative disease, and any change should be discussed with a clinician. This summarizes early research and is not medical advice.